Spinal Muscular Atrophy Phenotype Is Ameliorated Either By SMN Increase Or Modulation Of Secondary Cell Death Events With RNA Therapy (S56.006)
Page 1 of 1
Spinal Muscular Atrophy Phenotype Is Ameliorated Either By SMN Increase Or Modulation Of Secondary Cell Death Events With RNA Therapy (S56.006)
Jon Moulton Mon Apr 14, 2014 3:00 pm
Riboldi G, Nizzardo M, Simone C, Rizzo F, Ruggieri M, Pagliarani S, Ulzi G, Salani S, DalMas A, Bucchia M, Frattini E, Stuppia G, Magri F, Bresolin N, Pagani F, Comi G, Corti S. Spinal Muscular Atrophy Phenotype Is Ameliorated Either By SMN Increase Or Modulation Of Secondary Cell Death Events With RNA Therapy (S56.006). Neurology. 2014;82(10):Supplement S56.006
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches
» Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy
» Modeling the Early Phenotype at the Neuromuscular Junction of Spinal Muscular Atrophy Using Patient-Derived iPSCs
» Effect of Combined Systemic and Local Morpholino Treatment on the Spinal Muscular Atrophy Δ7 Mouse Model Phenotype
» Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
» Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy
» Modeling the Early Phenotype at the Neuromuscular Junction of Spinal Muscular Atrophy Using Patient-Derived iPSCs
» Effect of Combined Systemic and Local Morpholino Treatment on the Spinal Muscular Atrophy Δ7 Mouse Model Phenotype
» Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum|
|
|